Selling LEAPS And Covered Call Writing

 | Jun 11, 2017 01:32AM ET

In our BCI methodology we favor Monthly or Weekly options for our short covered call writing positions. I am frequently asked why I don’t utilize LEAPS options (expire 9 – 24 months in the future) to garner a much higher premium and perhaps require less management time. Dan recently sent me a covered call trade he executed with SLV (iShares Silver Trust (NYSE:SLV) using LEAPS as the short call position. He noted that his assessment was that SLV was undervalued and expected appreciation over the long-term.

Dan’s Trade

  • 11/21/2016: Buy SLV at $16.04
  • 11/21/2016: Sell the January 2019 LEAPS for $2.92
  • 11/28/2016: Share price declines to $15.26
  • 11/28/2016: “Ask” price for the LEAPS falls to $2.49

Dan’s question

“Can I buy back the LEAPS to lock in a $43.00 per contract profit and then sell more LEAPS and if so, will I still be considered “covered” since I don’t have naked option-trading privileges.

Response and evaluation of tactic

When buying back the option, we still own the underlying shares so, yes, we are still in a covered position when selling the second round of LEAPS. But does this action benefit us? After one week of being in this position, buying back the short call and re-selling it will result in a net debit due to the spread (Buying at the “ask” costs more than the credit generated from selling the “bid”). In addition to the spread net debit, we are also incurring two unnecessary trading commissions. Position management is critical but there are many occasions when the best action is no action at all.

A look at the technical chart